Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover study of salmeterol + fluticasone propionate versus fluticasone propionate alone versus placebo after allergen challenge in asthma
2007-001345-18Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Salmeterol + fluticasone propionate, Fluticasone propionate and Placebo (3 arms). Primary endpoint: Weighted mean change from baseline in blood eosinophils over 0 to 6 hours after allergen challenge. Started Jun 2007; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-001345-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001345-18.